RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.
Also called NCT01132456
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 312 participants
- Sponsor
- Registry
-
NCT01132456
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT01132456. Non-randomized; no masking; primary purpose treatment. Start 2010-06 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia
- Acronym
- R-A
- Condition
- Ischemic Heart Disease
- Condition
- Coronary Stenosis
- Condition
- Cardiovascular Diseases
- Condition
- Arteriosclerosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Drug eluting stent treatment
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct01132456- Content hash
782f45837d48ed0cdac4110ad28d9e7dd6249887e3be55dbdd4dd1a3a6e7a5ba